Trial Profile
A Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Different Doses of Indacaterol in Adult Patients With Persistent Asthma, Using Salmeterol as an Active Control.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Indacaterol; Salmeterol
- Indications Asthma
- Focus Therapeutic Use
- 29 Jul 2010 Actual end date added to 1 Jul 2010 as reported by ClinicalTrials.gov.
- 29 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.